HK111996A - Enantiomers of 2-tetrahydrofuran derivatives, intermediates therefor and their preparation - Google Patents

Enantiomers of 2-tetrahydrofuran derivatives, intermediates therefor and their preparation

Info

Publication number
HK111996A
HK111996A HK111996A HK111996A HK111996A HK 111996 A HK111996 A HK 111996A HK 111996 A HK111996 A HK 111996A HK 111996 A HK111996 A HK 111996A HK 111996 A HK111996 A HK 111996A
Authority
HK
Hong Kong
Prior art keywords
compound
formula
enantiomer
tetrahydrofuran
preparation
Prior art date
Application number
HK111996A
Other languages
German (de)
English (en)
French (fr)
Inventor
Estermann Heinrich
Koteswara Kapa Prasad
Joseph Houlihan William
Lee Underwood Russell
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HK111996A publication Critical patent/HK111996A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK111996A 1990-06-19 1996-06-27 Enantiomers of 2-tetrahydrofuran derivatives, intermediates therefor and their preparation HK111996A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54043890A 1990-06-19 1990-06-19
US64739691A 1991-01-29 1991-01-29

Publications (1)

Publication Number Publication Date
HK111996A true HK111996A (en) 1996-07-05

Family

ID=27066435

Family Applications (1)

Application Number Title Priority Date Filing Date
HK111996A HK111996A (en) 1990-06-19 1996-06-27 Enantiomers of 2-tetrahydrofuran derivatives, intermediates therefor and their preparation

Country Status (21)

Country Link
EP (1) EP0462935B1 (cs)
JP (1) JP2709330B2 (cs)
KR (1) KR920000772A (cs)
AT (1) ATE125261T1 (cs)
AU (2) AU649681B2 (cs)
CA (1) CA2044786A1 (cs)
CS (1) CS185191A3 (cs)
DE (1) DE69111311T2 (cs)
DK (1) DK0462935T3 (cs)
ES (1) ES2076502T3 (cs)
FI (1) FI912964A7 (cs)
GR (1) GR3017437T3 (cs)
HK (1) HK111996A (cs)
HU (1) HU210548B (cs)
IE (1) IE68417B1 (cs)
IL (1) IL98524A (cs)
MY (1) MY107022A (cs)
NZ (1) NZ238573A (cs)
PL (1) PL164981B1 (cs)
PT (1) PT97994B (cs)
TW (1) TW255897B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208352A (en) * 1992-04-02 1993-05-04 Sandoz Ltd. Process for preparing the R- and S-isomers of 2-hydroxy-methyl-2-octadecyloxymethyl-tetrahydrofuran and their use in preparing stereoisomers of pharmacologically active compounds
EP0973181B1 (en) * 1998-07-17 2002-10-09 Fuji Photo Film Co., Ltd. Photoelectric conversion device and photoelectrochemical cell

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0178261A3 (en) * 1984-10-10 1986-12-30 Sandoz Ag Substituted 2-furanyl or 5-oxo-2-furanyl-alkoxy phosphoryl alkyl cyclimmonium salts
US4601987A (en) * 1985-02-27 1986-07-22 Massachusetts Institute Of Technology Enzymatic production of optical isomers of 2-halopropionic acids
DE3666435D1 (en) * 1985-08-30 1989-11-23 Sandoz Ag Substituted hydroxy-heterocyclyl-alkoxy phosphinyloxy trialkylaminium hydroxide inner salt oxides, processes for their preparation and their use as pharmaceuticals
US4673672A (en) 1985-10-28 1987-06-16 Sandoz Pharmaceuticals Corp. Substituted-[hydroxy(tetrahydro)-5-oxo-(2- and 3-furanyl or 2-thienyl)alkoxyphosphinyloxy]-alkanaminium hydroxide, inner salt oxides
US4868319A (en) * 1987-12-22 1989-09-19 Sandoz Pharm. Corp. Process for the preparation of monoalkylcarbamate group-containing compounds

Also Published As

Publication number Publication date
IE912081A1 (en) 1992-01-01
IL98524A (en) 1995-12-31
AU7140794A (en) 1994-11-03
FI912964L (fi) 1991-12-20
IL98524A0 (en) 1992-07-15
CA2044786A1 (en) 1991-12-20
ATE125261T1 (de) 1995-08-15
JP2709330B2 (ja) 1998-02-04
GR3017437T3 (en) 1995-12-31
FI912964A0 (fi) 1991-06-18
AU677403B2 (en) 1997-04-24
PL164981B1 (pl) 1994-10-31
KR920000772A (ko) 1992-01-29
AU7843991A (en) 1992-01-02
MY107022A (en) 1995-08-30
HU911882D0 (en) 1991-12-30
HUT58340A (en) 1992-02-28
AU649681B2 (en) 1994-06-02
FI912964A7 (fi) 1991-12-20
EP0462935A1 (en) 1991-12-27
TW255897B (cs) 1995-09-01
NZ238573A (en) 1993-11-25
ES2076502T3 (es) 1995-11-01
EP0462935B1 (en) 1995-07-19
DE69111311T2 (de) 1996-03-14
PL290719A1 (en) 1992-07-27
PT97994B (pt) 1998-11-30
CS185191A3 (en) 1992-01-15
HU210548B (en) 1995-05-29
DK0462935T3 (da) 1995-11-06
DE69111311D1 (de) 1995-08-24
IE68417B1 (en) 1996-06-12
JPH04270276A (ja) 1992-09-25
PT97994A (pt) 1992-03-31

Similar Documents

Publication Publication Date Title
CH683996A5 (fr) Dérivés aminophosphonates substitués, leur procédé de préparation et compositions pharmaceutiques les contenant.
EP0639586B1 (fr) Dérivés d'acide phosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
JPH05239075A (ja) 含リンイソプレノイド誘導体
EP0462935B1 (en) Enantiomers of 2-tetrahydrofuran derivatives, intermediates therefor and their preparation
FR2707085A1 (fr) Nouveaux dérivés d'alpha amino acides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US6476062B2 (en) Chemokine receptor antagonists
CA1052810A (en) .omega.-(N-ACYLAMINO) ALKYLPHOSPHORYL ETHANOLAMINES, PROCESS FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USES
US4673672A (en) Substituted-[hydroxy(tetrahydro)-5-oxo-(2- and 3-furanyl or 2-thienyl)alkoxyphosphinyloxy]-alkanaminium hydroxide, inner salt oxides
EP0402033B1 (en) Carboxamide derivatives
US5229377A (en) Process for the preparation of the (R) stereoisomer of the monobutyric ester of 2,2-bis(hydroxymethyl)-tetrahydrofuran, its use in preparing stereoisomers of pharmacologically active compounds, and certain specific stereoisomers produced thereby
US5338730A (en) Use of the (R) isomer of 2-[(2-octa-decyloxymethyl-tetrahydro-2-furanylmethoxy)-hydroxyphosphinyloxy]-N,N,N-trimethylethanaminium hydroxide inner salt-4-oxide in treating multiple sclerosis
US4749696A (en) Hydroxy-[1-substituted carbonyl-2-(or 3-) piperidinyl methoxy]phosphinyloxy]-N,N,N-trialkylalkaneaminium hydroxide inner salt oxides having antitumor activity
EP0145177B1 (en) Chemotherapeutic agents based on rhizoxin
JPH0853387A (ja) 新規化合物ｆ−１１２６３
JPH04264092A (ja) シクロトリホスファゼンのｎ，ｏスピロ環状誘導体とその製法および用途
LU87543A1 (fr) Derives phosphoriques des mitomycines
AU665488B2 (en) New compound, leustroducsin H, its preparation and its therapeutic use
HK1007857B (en) New compound, leustroducsin h, its preparation and its therapeutic use
JPH09295980A (ja) 新規マクロライド系化合物０４０６
EP0812327A1 (en) Protein phosphatase inhibitor
FR2614303A1 (fr) Derives de nitrosourees, leur nouveau procede de preparation et leurs applications therapeutiques.
JPH0717905A (ja) Ｑ−６９１６化合物
FR2723748A1 (fr) Substances physiologiquement actives de type caledothricine, procede pour leur production, compositions pharmaceutiques les contenant et leur utilisation

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)